These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11464911

  • 1. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
    Tang XX, Evans AE, Zhao H, Cnaan A, Brodeur GM, Ikegaki N.
    Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
    Tang XX, Zhao H, Robinson ME, Cohen B, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N.
    Proc Natl Acad Sci U S A; 2000 Sep 26; 97(20):10936-41. PubMed ID: 10984508
    [Abstract] [Full Text] [Related]

  • 6. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.
    Cancer; 2004 Oct 15; 101(8):1873-81. PubMed ID: 15386308
    [Abstract] [Full Text] [Related]

  • 7. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.
    Clin Cancer Res; 1997 Oct 15; 3(10):1699-706. PubMed ID: 9815553
    [Abstract] [Full Text] [Related]

  • 8. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S, Ohira M, Isogai E, Nakada K, Nakagawara A.
    Int J Oncol; 2004 Jun 15; 24(6):1457-66. PubMed ID: 15138588
    [Abstract] [Full Text] [Related]

  • 9. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.
    Shimada A, Hirato J, Kuroiwa M, Kikuchi A, Hanada R, Wakai K, Hayashi Y.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):213-7. PubMed ID: 17941064
    [Abstract] [Full Text] [Related]

  • 10. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, Tonini GP, De Bernardi B, Calabretta B.
    Cancer Res; 1999 Jul 15; 59(14):3365-8. PubMed ID: 10416595
    [Abstract] [Full Text] [Related]

  • 11. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
    Hishiki T, Saito T, Terui K, Sato Y, Takenouchi A, Yahata E, Ono S, Nakagawara A, Kamijo T, Nakamura Y, Matsunaga T, Yoshida H.
    J Pediatr Surg; 2010 Dec 15; 45(12):2293-8. PubMed ID: 21129533
    [Abstract] [Full Text] [Related]

  • 12. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P, Oberthuer A, Fischer M, Westermann F, Eils R, Brors B.
    BMC Cancer; 2007 May 25; 7():89. PubMed ID: 17531100
    [Abstract] [Full Text] [Related]

  • 13. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
    Zhang J, Zheng Y, Wang Y, Tong H.
    J Pediatr Hematol Oncol; 2010 Apr 25; 32(3):180-4. PubMed ID: 20186105
    [Abstract] [Full Text] [Related]

  • 14. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT.
    J Clin Oncol; 2005 Sep 20; 23(27):6466-73. PubMed ID: 16116152
    [Abstract] [Full Text] [Related]

  • 15. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
    Kramer K, Gerald W, LeSauteur L, Uri Saragovi H, Cheung NK.
    Clin Cancer Res; 1996 Aug 15; 2(8):1361-7. PubMed ID: 9816308
    [Abstract] [Full Text] [Related]

  • 17. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
    Manohar CF, Salwen HR, Brodeur GM, Cohn SL.
    Genes Chromosomes Cancer; 1995 Nov 15; 14(3):196-203. PubMed ID: 8589036
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer.
    Zhu ZW, Friess H, Wang L, Di Mola FF, Zimmermann A, Büchler MW.
    Anticancer Res; 2000 Nov 15; 20(1A):125-32. PubMed ID: 10769644
    [Abstract] [Full Text] [Related]

  • 19. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
    de Souza DR, Sanabani SS, de Souza AC, Filho Odone V, Epelman S, Bendit I.
    Pediatr Blood Cancer; 2011 May 15; 56(5):749-56. PubMed ID: 21154590
    [Abstract] [Full Text] [Related]

  • 20. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
    Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H, Rappaport EF, Hicks SL, Seeger RC, Tang XX.
    Clin Cancer Res; 2007 Oct 15; 13(20):6001-9. PubMed ID: 17947461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.